By Rose Krebs ( April 15, 2019, 3:56 PM EDT) -- Citing high costs and trouble getting drug candidates beyond the clinical phase, biopharmaceutical company Achaogen Inc. on Monday filed for Chapter 11 protection in Delaware, listing between $50 million and $100 million in debt and planning a sale of its assets....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.